← All datasets

GSE122649

GSE GEO Potentially related
View on GEO Export SRA CSV

Postmortem Cortex Samples Identify Distinct Molecular Subtypes of ALS: Retrotransposon Activation, Oxidative Stress, and Activated Glia [motor cortex]

Organism: Homo sapiens
Platform: GPL18573
Samples: 38
Experiment Types:
Expression profiling by high throughput sequencing
Submitted: Nov 16 2018
Last Updated: Oct 31 2019
Status: Public on Sep 20 2019
Contact: Oliver,H,Tam (NYU Grossman School of Medicine)

Relations

SubSeries of: GSE122650 BioProject: https://www.ncbi.nlm.nih.gov/bioproject/PRJNA505842 SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRP169128

Summary

Amyotrophic Lateral Sclerosis (ALS) is a fatal neurodegenerative disease characterized by the progressive loss of motor neurons. While several inherited pathogenic mutations have been identified as causative, the vast majority of cases are sporadic with no family history of disease. Thus, for the majority of ALS cases, a specific causal abnormality is not known and the disease may be a product of multiple inter-related pathways contributing to varying degrees in different ALS patients. Using unsupervised machine learning algorithms, we stratified the transcriptomes of 148 ALS decedent cortex tissue samples into three distinct and robust molecular subtypes. The largest cluster, identified in 61% of patient samples, displayed hallmarks of oxidative and proteotoxic stress. Another 20% of the ALS patient samples exhibited high levels of retrotransposon expression and other signatures of TDP-43 dysfunction. Finally, a third group showed predominant signatures of glial activation (19%). Together these results demonstrate that at least three distinct molecular signatures contribute to ALS disease. While multiple dysregulated components and pathways comprising these clusters have previously been implicated in ALS pathogenesis, unbiased analysis of this large survey demonstrated that sporadic ALS patient tissues can be segregated into distinct molecular subsets.

Overall Design

RNA-seq analysis of sporadic ALS patient samples against those from individuals without neurological disorders

Analysis (3 steps)

View Data Processing
Processing steps for GSE122649
  1. Base calling performed with bcl2fastq conversion software v2.17
  2. Reads were aligned to hg19 genome using STAR v2.5.2b with the following configurations: --outFilterMultimapNmax 100; --outFilterMismatchNoverReadLmax 0.04
  3. Genes and TE were quantified using TEcount (from TEtranscripts v2.0.3) with the following configurations: hg19 genic GTF from refGene (Jan 2018), custom hg19 TE GTF generated from repeatMasker; --stranded reverse

Supplementary Files (1)

GSE122649_RAW.tar Download
GEO Samples (38)

Dataset Citations (1)

Potentially Related Publications (1)

This accession was text-mined from the PMC full text of these publications. It may be referenced for comparison or reused from another study rather than generated for them.

Data Files (10)

Accession File Name Stored Type Output Type Mapping Assembly Size Download
— Co-20.fastq.gz RNA-Seq 1.6 GB link
— Co-21.fastq.gz RNA-Seq 1.9 GB link
— Co-22.fastq.gz RNA-Seq 1.8 GB link
— Co-23.fastq.gz RNA-Seq 1.6 GB link
— Co-3.fastq.gz RNA-Seq 933.6 MB link
— Co-4.fastq.gz RNA-Seq 1.0 GB link
— Co-5.fastq.gz RNA-Seq 840.7 MB link
— Co-6.fastq.gz RNA-Seq 1016.9 MB link
— Co-7.fastq.gz RNA-Seq 1.7 GB link
— Co-8.fastq.gz RNA-Seq 2.0 GB link